| Multidrug resistance in tumour cells: characterisation of the multidrug resistant cell line K562-Lucena 1 VM Rumjanek, GS Trindade, K Wagner-Souza, MC Meletti-de-Oliveira, ... Anais da Academia Brasileira de Ciências 73 (1), 57-69, 2001 | 151 | 2001 |
| FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance GN de Moraes, D Delbue, KL Silva, MC Robaina, P Khongkow, ... Cellular signalling 27 (12), 2496-2505, 2015 | 125 | 2015 |
| Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines? VM Rumjanek, RS Vidal, RC Maia Bioscience reports 33 (6), 2013 | 98 | 2013 |
| Geographic variation in Epstein‐Barr virus–associated Burkitt's lymphoma in children from Brazil CE Klumb, R Hassan, DE De Oliveira, LMM De Resende, MK Carriço, ... International journal of cancer 108 (1), 66-70, 2004 | 73 | 2004 |
| Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature RC Maia, E de Meis, S Romano, JA Dobbin, CE Klumb Brazilian Journal of Medical and Biological Research 48, 06-12, 2014 | 68 | 2014 |
| Comparison of the cytotoxic effect of lapachol, α-lapachone and pentacyclic 1, 4-naphthoquinones on human leukemic cells EJS Salustiano, CD Netto, RF Fernandes, AJM da Silva, TS Bacelar, ... Investigational new drugs 28 (2), 139-144, 2010 | 68 | 2010 |
| Towards comprehension of the ABCB1/P-glycoprotein role in chronic myeloid leukemia R Maia, F Vasconcelos, P Souza, V Rumjanek Molecules 23 (1), 119, 2018 | 57 | 2018 |
| The interface between BCR-ABL-dependent and-independent resistance signaling pathways in chronic myeloid leukemia G Nestal de Moraes, PS Souza, FCF Costas, FC Vasconcelos, FRS Reis, ... Leukemia research and treatment 2012, 2012 | 55 | 2012 |
| Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients FC Vasconcelos, KL Silva, PS Souza, LFR Silva, A Moellmann‐Coelho, ... Cytometry Part B: Clinical Cytometry 80 (3), 158-166, 2011 | 52 | 2011 |
| Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels GN de Moraes, FC Vasconcelos, D Delbue, GP Mognol, C Sternberg, ... European journal of cell biology 92 (8-9), 247-256, 2013 | 47 | 2013 |
| Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil CE Klumb, MT Schramm, LMM de Resende, MK Carriço, AM Coelho, ... Journal of pediatric hematology/oncology 26 (7), 462-468, 2004 | 47 | 2004 |
| Differences in the expression pattern of P-glycoprotein and MRP1 in low-grade and high-grade gliomas GP de Faria, JA de Oliveira, JGP de Oliveira, SO Romano, VM Neto, ... Cancer investigation 26 (9), 883-889, 2008 | 46 | 2008 |
| Mitotracker Green Is a P-Glycoprotein Substrate LF Marques-Santos, JGP Oliveira, RC Maia, VM Rumjanek Bioscience reports 23 (4), 199-212, 2003 | 45 | 2003 |
| LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1, 4-naphthoquinone]: a novel class of agent with high apoptotic effect in … RC Maia, FC Vasconcelos, T de Sá Bacelar, EJ Salustiano, LFR da Silva, ... Investigational new drugs 29 (6), 1143-1155, 2011 | 44 | 2011 |
| Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia FR Reis, FC Vasconcelos, DL PeReIRA, A Moellman-Coelho, KL Silva, ... Oncology reports 26 (2), 471-478, 2011 | 44 | 2011 |
| FOXK2 transcription factor and its emerging roles in cancer G Nestal de Moraes, LT Carneiro, RC Maia, EWF Lam, AD Sharrocks Cancers 11 (3), 393, 2019 | 43 | 2019 |
| FOXK2 Transcription Factor and Its Emerging Roles in Cancer G Nestal de Moraes, LT Carneiro, RC Maia, EWF Lam, AD Sharrocks Cancers 11 (3), 393, 2019 | 43 | 2019 |
| Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type PS de Souza, ALS Cruz, JPB Viola, RC Maia Cancer science 106 (1), 60-68, 2015 | 43 | 2015 |
| P-glycoprotein and survivin simultaneously regulate vincristine-induced apoptosis in chronic myeloid leukemia cells PS Souza, FC Vasconcelos, FR De Souza Reis, GN De Moraes, RC Maia International journal of oncology 39 (4), 925-933, 2011 | 43 | 2011 |
| Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile FC Vasconcelos, CR Gattass, VM Rumjanek, RC Maia Investigational new drugs 25 (6), 525-533, 2007 | 40 | 2007 |
